Evidence map›Paper›PMID 28781859›Full record

ArticleClinical case reports2017

Hematuria as the first sign of multiple myeloma.

Mariana Alves, Raul Moreno, Fátima Rodrigues, Anabela Rodrigues, Teresa Fonseca

Abstract readCase Reports
In one paragraph

Article in Clinical case reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mariana AlvesCHLN Medicina III Hospital Pulido Valente Lisboa Portugal.ORCID 0000-0002-1369-8423
Raul MorenoCHLN Hematologia e Transplantação Medular Hospital Santa Maria Lisboa Portugal.
Fátima RodriguesCHLN Imuno-hemoterapia Hospital Santa Maria Lisboa Portugal.
Anabela RodriguesCHLN Imuno-hemoterapia Hospital Santa Maria Lisboa Portugal.
Teresa FonsecaCHLN Medicina III Hospital Pulido Valente Lisboa Portugal.

Funding

Project 4: Targeting Resistance to T-Cell Directed Therapy in Multiple MyelomaP50CA186781 · NCI · MAYO CLINIC ARIZONA · PI Amylou Constance Dueck · 2015 to 2026
$25.5M
NCI NIH HHS P50 CA186781
6 · The paper itself

Abstract

Patients with multiple myeloma may present with several signs and symptoms, inclusive of hemorrhagic diathesis. This case emphasizes the need to suspect uncommon etiologies for common signs and to be aware of the atypical effects of paraproteinemia.

Indexed as

hematurialupus coagulation inhibitormultiple myeloma

Identifiers

PMID28781859
PMCPMC5538104

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.